A core belief regarding the involvement of the cellular mitochondria, as the centre for metabolic function, has led Sigma-tau SpA (Italy) and Sigma-tau HealthScience (Italy) to develop Metabolic Approach, what it describes as athe definitive means to nutritional support for optimum metabolic function'.
By adopting the metabolic approach the companies deal not with L-carnitine deficiencies, rather, L-carnitine insufficiencies in regards to the support of cell health. L-carnitine, when synthesised in our bodies, is itself derived from amino acids. In the vast prevalence of L-carnitine insufficiencies that occur today in our diets, the scientific literature indicates possible insufficiencies of certain amino acids as well.
Providing both L-carnitine and amino acids as an intimate within a finished formulation leads to challenges in content uniformity during blending and shaping the finished form, as well as a highly probable uneven uptake during dissociation The companies' AminoCarnitines simultaneously deliver a uniform ratio of carnitine and a specifically associated amino acid within the same molecule. As dissociation of the AminoCarnitine occurs, molecule by molecule, a specific amount of amino acid becomes simultaneously available for absorption.
Sigma-tau SpA (Italy) and Sigma-tau HealthScience (Italy) are based in Rome, Italy. www.sigma-tau.it or www.st-hs.com
